Hacker group claims to have stolen drug data from Ozempic owner

Ozempic: weight-loss pen used in the treatment of diabetes and obesity Disclosure A hacker group claimed on Tuesday (16) that it stole 1.3 terabytes of data from Danish pharmaceutical company Novo Nordisk, known for its diabetes and obesity treatments such as Ozempic and Wegovy. Named FulcrumSec and created in October 2025, the group said it is considering selling some of the data after failing in an attempt to charge $25 million to return the material to the company. 🗒️ Have a news tip? Send it to g1 The hackers attacked Novo Nordisk's systems in March and remained embedded in the company's networks for two months until they secured a list of over 700,000 files, according to what they told cybersecurity website DataBreaches.Net. Novo Nordisk had already reported last Thursday (11) that it suffered a cybersecurity incident. According to the company, the attack involved unauthorized access to a limited number of internal systems and personal data of some clinical trial patients. Now on g1 FulcrumSec said the breach allowed access to data from 11,500 clinical trial patients and thousands of employees, as well as details on processing facilities and artificial intelligence models used by the company. The group also claimed it gained access to data such as Novo Nordisk's source code, data on released and unreleased drugs, clinical trial documents, among others. FulcrumSec said it does not intend to share data belonging to Novo Nordisk employees and patients, nor regarding the operation of systems used at the company's facilities. Novo Nordisk told Reuters that it "is aware of allegations that data allegedly copied externally without authorization from our systems has been published online." "We take this matter seriously and maintain the continuous operation of our core platforms.

We are in contact with the relevant authorities," the company stated.